0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global SPECT Radiopharmaceuticals Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-19D820
Home | Market Reports | Business & Industrial| Business Services
Global SPECT Radiopharmaceuticals Market Insights Forecast to 2028
BUY CHAPTERS

Global SPECT Radiopharmaceuticals Market Research Report 2025

Code: QYRE-Auto-19D820
Report
March 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

SPECT Radiopharmaceuticals Market Size

The global market for SPECT Radiopharmaceuticals was valued at US$ 5169 million in the year 2024 and is projected to reach a revised size of US$ 15040 million by 2031, growing at a CAGR of 16.7% during the forecast period.

SPECT Radiopharmaceuticals Market

SPECT Radiopharmaceuticals Market

SPECT (Single Photon Emission Computed Tomography) radiopharmaceuticals are compounds that contain a radioactive isotope used in conjunction with SPECT imaging techniques. These radiopharmaceuticals emit gamma radiation, which is detected by a gamma camera during a SPECT scan, creating detailed 3D images of the internal structures and functions of the body. These radiopharmaceuticals are primarily used for diagnostic imaging, allowing healthcare providers to evaluate the function of organs, tissues, and systems without invasive procedures.
SPECT radiopharmaceuticals are a type of radioactive tracers used in nuclear medicine imaging that can help doctors detect heart disease, neurological diseases, cancer, bone diseases, and thyroid diseases. They rely on short-half-life radioisotopes to obtain physiological function information through SPECT scanners, and have important applications in modern medicine.
From a regional perspective, North America and Europe have advanced medical infrastructure and strong R&D capabilities. As the world's largest radiopharmaceutical market, they have promoted the widespread use of SPECT radiopharmaceuticals. The increase in medical demand in emerging markets such as Asia Pacific and Latin America will provide new growth momentum for the SPECT radiopharmaceutical market.
Global leading suppliers include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, etc. The production of radiopharmaceuticals requires complex nuclear technology and strict safety supervision. These high technical barriers limit the entry of new companies and maintain the stability of the market.
With the advancement of medical technology, new radioisotopes and labeling methods will be developed to improve the accuracy and efficiency of SPECT imaging and promote market development.
This report aims to provide a comprehensive presentation of the global market for SPECT Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SPECT Radiopharmaceuticals.
The SPECT Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global SPECT Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the SPECT Radiopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of SPECT Radiopharmaceuticals Market Report

Report Metric Details
Report Name SPECT Radiopharmaceuticals Market
Accounted market size in year US$ 5169 million
Forecasted market size in 2031 US$ 15040 million
CAGR 16.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Technetium-99m (Tc-99m) Based Agents
  • Iodine-123 (I-123) Based Agents
  • Gallium-67 (Ga-67)
  • Indium-111 (In-111) Based Agents
  • Thallium-201 (Tl-201)
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Eczacibasi-Monrol, Siemens Healthineers, Bayer (Radiology Division), Molecular Imaging, Inc., NorthStar Medical Radioisotopes, Advanced Accelerator Applications, IBA Molecular Imaging
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of SPECT Radiopharmaceuticals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is SPECT Radiopharmaceuticals Market growing?

Ans: The SPECT Radiopharmaceuticals Market witnessing a CAGR of 16.7% during the forecast period 2025-2031.

What is the SPECT Radiopharmaceuticals Market size in 2031?

Ans: The SPECT Radiopharmaceuticals Market size in 2031 will be US$ 15040 million.

Who are the main players in the SPECT Radiopharmaceuticals Market report?

Ans: The main players in the SPECT Radiopharmaceuticals Market are GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, Eczacibasi-Monrol, Siemens Healthineers, Bayer (Radiology Division), Molecular Imaging, Inc., NorthStar Medical Radioisotopes, Advanced Accelerator Applications, IBA Molecular Imaging

What are the Application segmentation covered in the SPECT Radiopharmaceuticals Market report?

Ans: The Applications covered in the SPECT Radiopharmaceuticals Market report are Cardiac Imaging, Cancer Imaging, Brain Imaging, Thyroid Imaging, Infection and Inflammation Imaging

What are the Type segmentation covered in the SPECT Radiopharmaceuticals Market report?

Ans: The Types covered in the SPECT Radiopharmaceuticals Market report are Technetium-99m (Tc-99m) Based Agents, Iodine-123 (I-123) Based Agents, Gallium-67 (Ga-67), Indium-111 (In-111) Based Agents, Thallium-201 (Tl-201)

Recommended Reports

Radiopharmaceuticals Market

Nuclear Medicine Devices

Nuclear Medicine Agents

Market trends :

Topic Trends
Global the spect radiopharmaceuticals market is experiencing rapid growth driven by technological advancements in radioisotope development and increasing adoption in emerging markets with expanding healthcare infrastructure.
Region North America - north america maintains market leadership in spect radiopharmaceuticals due to advanced medical infrastructure and strong research and development capabilities.
EMEA - europe continues to drive spect radiopharmaceuticals adoption with robust regulatory frameworks and increasing investments in nuclear medicine technologies.
APAC - asia pacific is emerging as a key growth region for spect radiopharmaceuticals fueled by rising healthcare demand and expanding diagnostic imaging capacity.
LATAM - latin america is witnessing increased uptake of spect radiopharmaceuticals as healthcare access improves and investment in diagnostic imaging rises.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Technetium-99m (Tc-99m) Based Agents
1.2.3 Iodine-123 (I-123) Based Agents
1.2.4 Gallium-67 (Ga-67)
1.2.5 Indium-111 (In-111) Based Agents
1.2.6 Thallium-201 (Tl-201)
1.3 Market by Application
1.3.1 Global SPECT Radiopharmaceuticals Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiac Imaging
1.3.3 Cancer Imaging
1.3.4 Brain Imaging
1.3.5 Thyroid Imaging
1.3.6 Infection and Inflammation Imaging
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global SPECT Radiopharmaceuticals Market Perspective (2020-2031)
2.2 Global SPECT Radiopharmaceuticals Growth Trends by Region
2.2.1 Global SPECT Radiopharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 SPECT Radiopharmaceuticals Historic Market Size by Region (2020-2025)
2.2.3 SPECT Radiopharmaceuticals Forecasted Market Size by Region (2026-2031)
2.3 SPECT Radiopharmaceuticals Market Dynamics
2.3.1 SPECT Radiopharmaceuticals Industry Trends
2.3.2 SPECT Radiopharmaceuticals Market Drivers
2.3.3 SPECT Radiopharmaceuticals Market Challenges
2.3.4 SPECT Radiopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top SPECT Radiopharmaceuticals Players by Revenue
3.1.1 Global Top SPECT Radiopharmaceuticals Players by Revenue (2020-2025)
3.1.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Players (2020-2025)
3.2 Global Top SPECT Radiopharmaceuticals Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by SPECT Radiopharmaceuticals Revenue
3.4 Global SPECT Radiopharmaceuticals Market Concentration Ratio
3.4.1 Global SPECT Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by SPECT Radiopharmaceuticals Revenue in 2024
3.5 Global Key Players of SPECT Radiopharmaceuticals Head office and Area Served
3.6 Global Key Players of SPECT Radiopharmaceuticals, Product and Application
3.7 Global Key Players of SPECT Radiopharmaceuticals, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 SPECT Radiopharmaceuticals Breakdown Data by Type
4.1 Global SPECT Radiopharmaceuticals Historic Market Size by Type (2020-2025)
4.2 Global SPECT Radiopharmaceuticals Forecasted Market Size by Type (2026-2031)
5 SPECT Radiopharmaceuticals Breakdown Data by Application
5.1 Global SPECT Radiopharmaceuticals Historic Market Size by Application (2020-2025)
5.2 Global SPECT Radiopharmaceuticals Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America SPECT Radiopharmaceuticals Market Size (2020-2031)
6.2 North America SPECT Radiopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America SPECT Radiopharmaceuticals Market Size by Country (2020-2025)
6.4 North America SPECT Radiopharmaceuticals Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe SPECT Radiopharmaceuticals Market Size (2020-2031)
7.2 Europe SPECT Radiopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe SPECT Radiopharmaceuticals Market Size by Country (2020-2025)
7.4 Europe SPECT Radiopharmaceuticals Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific SPECT Radiopharmaceuticals Market Size (2020-2031)
8.2 Asia-Pacific SPECT Radiopharmaceuticals Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific SPECT Radiopharmaceuticals Market Size by Region (2020-2025)
8.4 Asia-Pacific SPECT Radiopharmaceuticals Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America SPECT Radiopharmaceuticals Market Size (2020-2031)
9.2 Latin America SPECT Radiopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America SPECT Radiopharmaceuticals Market Size by Country (2020-2025)
9.4 Latin America SPECT Radiopharmaceuticals Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa SPECT Radiopharmaceuticals Market Size (2020-2031)
10.2 Middle East & Africa SPECT Radiopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2020-2025)
10.4 Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare SPECT Radiopharmaceuticals Introduction
11.1.4 GE Healthcare Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.1.5 GE Healthcare Recent Development
11.2 Cardinal Health
11.2.1 Cardinal Health Company Details
11.2.2 Cardinal Health Business Overview
11.2.3 Cardinal Health SPECT Radiopharmaceuticals Introduction
11.2.4 Cardinal Health Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.2.5 Cardinal Health Recent Development
11.3 Lantheus Medical Imaging
11.3.1 Lantheus Medical Imaging Company Details
11.3.2 Lantheus Medical Imaging Business Overview
11.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Introduction
11.3.4 Lantheus Medical Imaging Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.3.5 Lantheus Medical Imaging Recent Development
11.4 Bracco Imaging
11.4.1 Bracco Imaging Company Details
11.4.2 Bracco Imaging Business Overview
11.4.3 Bracco Imaging SPECT Radiopharmaceuticals Introduction
11.4.4 Bracco Imaging Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.4.5 Bracco Imaging Recent Development
11.5 Curium Pharma
11.5.1 Curium Pharma Company Details
11.5.2 Curium Pharma Business Overview
11.5.3 Curium Pharma SPECT Radiopharmaceuticals Introduction
11.5.4 Curium Pharma Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.5.5 Curium Pharma Recent Development
11.6 Eczacibasi-Monrol
11.6.1 Eczacibasi-Monrol Company Details
11.6.2 Eczacibasi-Monrol Business Overview
11.6.3 Eczacibasi-Monrol SPECT Radiopharmaceuticals Introduction
11.6.4 Eczacibasi-Monrol Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.6.5 Eczacibasi-Monrol Recent Development
11.7 Siemens Healthineers
11.7.1 Siemens Healthineers Company Details
11.7.2 Siemens Healthineers Business Overview
11.7.3 Siemens Healthineers SPECT Radiopharmaceuticals Introduction
11.7.4 Siemens Healthineers Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.7.5 Siemens Healthineers Recent Development
11.8 Bayer (Radiology Division)
11.8.1 Bayer (Radiology Division) Company Details
11.8.2 Bayer (Radiology Division) Business Overview
11.8.3 Bayer (Radiology Division) SPECT Radiopharmaceuticals Introduction
11.8.4 Bayer (Radiology Division) Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.8.5 Bayer (Radiology Division) Recent Development
11.9 Molecular Imaging, Inc.
11.9.1 Molecular Imaging, Inc. Company Details
11.9.2 Molecular Imaging, Inc. Business Overview
11.9.3 Molecular Imaging, Inc. SPECT Radiopharmaceuticals Introduction
11.9.4 Molecular Imaging, Inc. Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.9.5 Molecular Imaging, Inc. Recent Development
11.10 NorthStar Medical Radioisotopes
11.10.1 NorthStar Medical Radioisotopes Company Details
11.10.2 NorthStar Medical Radioisotopes Business Overview
11.10.3 NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Introduction
11.10.4 NorthStar Medical Radioisotopes Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.10.5 NorthStar Medical Radioisotopes Recent Development
11.11 Advanced Accelerator Applications
11.11.1 Advanced Accelerator Applications Company Details
11.11.2 Advanced Accelerator Applications Business Overview
11.11.3 Advanced Accelerator Applications SPECT Radiopharmaceuticals Introduction
11.11.4 Advanced Accelerator Applications Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.11.5 Advanced Accelerator Applications Recent Development
11.12 IBA Molecular Imaging
11.12.1 IBA Molecular Imaging Company Details
11.12.2 IBA Molecular Imaging Business Overview
11.12.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Introduction
11.12.4 IBA Molecular Imaging Revenue in SPECT Radiopharmaceuticals Business (2020-2025)
11.12.5 IBA Molecular Imaging Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global SPECT Radiopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Technetium-99m (Tc-99m) Based Agents
 Table 3. Key Players of Iodine-123 (I-123) Based Agents
 Table 4. Key Players of Gallium-67 (Ga-67)
 Table 5. Key Players of Indium-111 (In-111) Based Agents
 Table 6. Key Players of Thallium-201 (Tl-201)
 Table 7. Global SPECT Radiopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global SPECT Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global SPECT Radiopharmaceuticals Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global SPECT Radiopharmaceuticals Market Share by Region (2020-2025)
 Table 11. Global SPECT Radiopharmaceuticals Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global SPECT Radiopharmaceuticals Market Share by Region (2026-2031)
 Table 13. SPECT Radiopharmaceuticals Market Trends
 Table 14. SPECT Radiopharmaceuticals Market Drivers
 Table 15. SPECT Radiopharmaceuticals Market Challenges
 Table 16. SPECT Radiopharmaceuticals Market Restraints
 Table 17. Global SPECT Radiopharmaceuticals Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global SPECT Radiopharmaceuticals Market Share by Players (2020-2025)
 Table 19. Global Top SPECT Radiopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SPECT Radiopharmaceuticals as of 2024)
 Table 20. Ranking of Global Top SPECT Radiopharmaceuticals Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by SPECT Radiopharmaceuticals Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of SPECT Radiopharmaceuticals, Headquarters and Area Served
 Table 23. Global Key Players of SPECT Radiopharmaceuticals, Product and Application
 Table 24. Global Key Players of SPECT Radiopharmaceuticals, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global SPECT Radiopharmaceuticals Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
 Table 28. Global SPECT Radiopharmaceuticals Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2026-2031)
 Table 30. Global SPECT Radiopharmaceuticals Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
 Table 32. Global SPECT Radiopharmaceuticals Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2026-2031)
 Table 34. North America SPECT Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America SPECT Radiopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America SPECT Radiopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe SPECT Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe SPECT Radiopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe SPECT Radiopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific SPECT Radiopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific SPECT Radiopharmaceuticals Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific SPECT Radiopharmaceuticals Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America SPECT Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America SPECT Radiopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America SPECT Radiopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa SPECT Radiopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)
 Table 49. GE Healthcare Company Details
 Table 50. GE Healthcare Business Overview
 Table 51. GE Healthcare SPECT Radiopharmaceuticals Product
 Table 52. GE Healthcare Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 53. GE Healthcare Recent Development
 Table 54. Cardinal Health Company Details
 Table 55. Cardinal Health Business Overview
 Table 56. Cardinal Health SPECT Radiopharmaceuticals Product
 Table 57. Cardinal Health Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 58. Cardinal Health Recent Development
 Table 59. Lantheus Medical Imaging Company Details
 Table 60. Lantheus Medical Imaging Business Overview
 Table 61. Lantheus Medical Imaging SPECT Radiopharmaceuticals Product
 Table 62. Lantheus Medical Imaging Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 63. Lantheus Medical Imaging Recent Development
 Table 64. Bracco Imaging Company Details
 Table 65. Bracco Imaging Business Overview
 Table 66. Bracco Imaging SPECT Radiopharmaceuticals Product
 Table 67. Bracco Imaging Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 68. Bracco Imaging Recent Development
 Table 69. Curium Pharma Company Details
 Table 70. Curium Pharma Business Overview
 Table 71. Curium Pharma SPECT Radiopharmaceuticals Product
 Table 72. Curium Pharma Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 73. Curium Pharma Recent Development
 Table 74. Eczacibasi-Monrol Company Details
 Table 75. Eczacibasi-Monrol Business Overview
 Table 76. Eczacibasi-Monrol SPECT Radiopharmaceuticals Product
 Table 77. Eczacibasi-Monrol Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 78. Eczacibasi-Monrol Recent Development
 Table 79. Siemens Healthineers Company Details
 Table 80. Siemens Healthineers Business Overview
 Table 81. Siemens Healthineers SPECT Radiopharmaceuticals Product
 Table 82. Siemens Healthineers Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 83. Siemens Healthineers Recent Development
 Table 84. Bayer (Radiology Division) Company Details
 Table 85. Bayer (Radiology Division) Business Overview
 Table 86. Bayer (Radiology Division) SPECT Radiopharmaceuticals Product
 Table 87. Bayer (Radiology Division) Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 88. Bayer (Radiology Division) Recent Development
 Table 89. Molecular Imaging, Inc. Company Details
 Table 90. Molecular Imaging, Inc. Business Overview
 Table 91. Molecular Imaging, Inc. SPECT Radiopharmaceuticals Product
 Table 92. Molecular Imaging, Inc. Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 93. Molecular Imaging, Inc. Recent Development
 Table 94. NorthStar Medical Radioisotopes Company Details
 Table 95. NorthStar Medical Radioisotopes Business Overview
 Table 96. NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Product
 Table 97. NorthStar Medical Radioisotopes Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 98. NorthStar Medical Radioisotopes Recent Development
 Table 99. Advanced Accelerator Applications Company Details
 Table 100. Advanced Accelerator Applications Business Overview
 Table 101. Advanced Accelerator Applications SPECT Radiopharmaceuticals Product
 Table 102. Advanced Accelerator Applications Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 103. Advanced Accelerator Applications Recent Development
 Table 104. IBA Molecular Imaging Company Details
 Table 105. IBA Molecular Imaging Business Overview
 Table 106. IBA Molecular Imaging SPECT Radiopharmaceuticals Product
 Table 107. IBA Molecular Imaging Revenue in SPECT Radiopharmaceuticals Business (2020-2025) & (US$ Million)
 Table 108. IBA Molecular Imaging Recent Development
 Table 109. Research Programs/Design for This Report
 Table 110. Key Data Information from Secondary Sources
 Table 111. Key Data Information from Primary Sources
 Table 112. Authors List of This Report


List of Figures
 Figure 1. SPECT Radiopharmaceuticals Picture
 Figure 2. Global SPECT Radiopharmaceuticals Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global SPECT Radiopharmaceuticals Market Share by Type: 2024 VS 2031
 Figure 4. Technetium-99m (Tc-99m) Based Agents Features
 Figure 5. Iodine-123 (I-123) Based Agents Features
 Figure 6. Gallium-67 (Ga-67) Features
 Figure 7. Indium-111 (In-111) Based Agents Features
 Figure 8. Thallium-201 (Tl-201) Features
 Figure 9. Global SPECT Radiopharmaceuticals Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global SPECT Radiopharmaceuticals Market Share by Application: 2024 VS 2031
 Figure 11. Cardiac Imaging Case Studies
 Figure 12. Cancer Imaging Case Studies
 Figure 13. Brain Imaging Case Studies
 Figure 14. Thyroid Imaging Case Studies
 Figure 15. Infection and Inflammation Imaging Case Studies
 Figure 16. SPECT Radiopharmaceuticals Report Years Considered
 Figure 17. Global SPECT Radiopharmaceuticals Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global SPECT Radiopharmaceuticals Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global SPECT Radiopharmaceuticals Market Share by Region: 2024 VS 2031
 Figure 20. Global SPECT Radiopharmaceuticals Market Share by Players in 2024
 Figure 21. Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 22. The Top 10 and 5 Players Market Share by SPECT Radiopharmaceuticals Revenue in 2024
 Figure 23. North America SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America SPECT Radiopharmaceuticals Market Share by Country (2020-2031)
 Figure 25. United States SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe SPECT Radiopharmaceuticals Market Share by Country (2020-2031)
 Figure 29. Germany SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific SPECT Radiopharmaceuticals Market Share by Region (2020-2031)
 Figure 37. China SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America SPECT Radiopharmaceuticals Market Share by Country (2020-2031)
 Figure 45. Mexico SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa SPECT Radiopharmaceuticals Market Share by Country (2020-2031)
 Figure 49. Turkey SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE SPECT Radiopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. GE Healthcare Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 53. Cardinal Health Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 54. Lantheus Medical Imaging Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 55. Bracco Imaging Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 56. Curium Pharma Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 57. Eczacibasi-Monrol Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 58. Siemens Healthineers Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 59. Bayer (Radiology Division) Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 60. Molecular Imaging, Inc. Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 61. NorthStar Medical Radioisotopes Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 62. Advanced Accelerator Applications Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 63. IBA Molecular Imaging Revenue Growth Rate in SPECT Radiopharmaceuticals Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS